Thompson Davis & Co’s Surmodics SRDX Stock Holding History

Thompson Davis & Co’s Portfolio SRDX Stock Details SRDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	$101K	Buy	1,350 +550	+69%	+$37.9K	0.22%	106
2018 Q2	$44K	Buy	+800	New	+$37K	0.1%	215

Other funds holding SRDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Thompson Davis & Co's SRDX Position: Q3 2018 in Review

Thompson Davis & Co increased its Surmodics (SRDX) stake by 69% in Q3 2018, buying an estimated $37.9K and bringing the position to 1,350 shares worth $101K. The position accounts for 0.22% of the portfolio, ranked #106.

Thompson Davis & Co first reported a position in SRDX in Q2 2018 and has held it in 2 quarters since. 168 funds tracked by Wall St. Rank hold SRDX as of Q3 2018.

Thompson Davis & Co held 1,350 shares of Surmodics worth $101K as of Q3 2018.
Thompson Davis & Co bought 550 Surmodics shares in Q3 2018, an estimated $37.9K.
Surmodics made up 0.22% of Thompson Davis & Co's portfolio in Q3 2018, its #106 holding.
Thompson Davis & Co first reported a position in Surmodics in Q2 2018 and has held it in 2 quarters since.
168 funds tracked by Wall St. Rank held Surmodics as of Q3 2018.

Based on Thompson Davis & Co's 13F filing for Q3 2018, filed 14 Nov 2018.